Therapeutic RSK1 Targeting in Myelofibrosis
Washington University School of Medicine
Washington University School of Medicine
Thomas Jefferson University
Seattle Children's Hospital
Amgen
Uskudar University
Istanbul University
Taiga Biotechnologies, Inc.
Janssen-Cilag International NV
Valerio Therapeutics
Janssen-Cilag International NV
Instituto Materno Infantil Prof. Fernando Figueira
Scios, Inc.
Alaunos Therapeutics